Literature DB >> 10940951

Redefinition: coping with normal results from predictive gene testing for neurodegenerative disorders.

J K Williams1, D L Schutte, C Evers, P A Holkup.   

Abstract

The purpose of this qualitative study was to describe the psychosocial impact and coping processes of normal (negative) results from predictive testing for an inherited neurodegenerative disease. Ten adults with normal results of predictive testing for the Huntington disease (HD) or the Pallido-Ponto-Nigral Degeneration (PPND) gene mutation participated in semi-structured interviews 1 month after receiving results, and seven of these participants were interviewed 6 months later. The major theme of Redefinition was derived using Knafl and Webster's analysis method (1988). People who received normal gene results experienced loss of former beliefs about themselves and developed new self definitions, relationships with family, and roles in society. This coping process evolved from a personal focus at 1 month to a broader future perspective at 6 months after testing. Identifying components of the redefinition process may be an important consideration in planning interventions to promote coping with normal gene results in persons within at-risk families. Copyright 2000 John Wiley & Sons,

Entities:  

Mesh:

Year:  2000        PMID: 10940951     DOI: 10.1002/1098-240x(200008)23:4<260::aid-nur2>3.0.co;2-c

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  12 in total

1.  Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Robin L Bennett; Kimberly A Hart; Erin O'Rourke; John A Barranger; Jack Johnson; Kay D MacDermot; Gregory M Pastores; Robert D Steiner; Ravi Thadhani
Journal:  J Genet Couns       Date:  2002-04       Impact factor: 2.537

2.  What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington's Disease.

Authors:  Elisabeth Winnberg; Ulrika Winnberg; Lilian Pohlkamp; Anette Hagberg
Journal:  J Genet Couns       Date:  2018-04-07       Impact factor: 2.537

3.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

Review 4.  What is the role of genetic testing in movement disorders practice?

Authors:  Susanne A Schneider; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

5.  Using the impact of event scale to evaluate psychological response to being a phenylketonuria gene carrier.

Authors:  Catherine Y Read
Journal:  J Genet Couns       Date:  2004-06       Impact factor: 2.537

6.  The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.

Authors:  Sato Ashida; Laura M Koehly; J Scott Roberts; Clara A Chen; Susan Hiraki; Robert C Green
Journal:  Eur J Hum Genet       Date:  2010-07-28       Impact factor: 4.246

7.  Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.

Authors:  Dawn A Laney; Robin L Bennett; Virginia Clarke; Angela Fox; Robert J Hopkin; Jack Johnson; Erin O'Rourke; Katherine Sims; Gerald Walter
Journal:  J Genet Couns       Date:  2013-07-17       Impact factor: 2.537

Review 8.  Nursing advocacy in a postgenomic age.

Authors:  Rebekah Hamilton
Journal:  Nurs Clin North Am       Date:  2009-12       Impact factor: 1.208

9.  Living at risk: concealing risk and preserving hope in Huntington disease.

Authors:  Kimberly A Quaid; Sharon L Sims; Melinda M Swenson; Joan M Harrison; Carol Moskowitz; Nonna Stepanov; Gregory W Suter; Beryl J Westphal
Journal:  J Genet Couns       Date:  2007-10-18       Impact factor: 2.537

10.  Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease.

Authors:  Elizabeth Penziner; Janet K Williams; Cheryl Erwin; Yvonne Bombard; Anne Wallis; Leigh J Beglinger; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-04-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.